Correction: Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression.

Journal

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
ISSN: 1740-634X
Titre abrégé: Neuropsychopharmacology
Pays: England
ID NLM: 8904907

Informations de publication

Date de publication:
Jul 2020
Historique:
pubmed: 8 5 2020
medline: 8 5 2020
entrez: 8 5 2020
Statut: ppublish

Résumé

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiants

DOI: 10.1038/s41386-020-0699-7 PMID: 32376872 PMC: PMC7414102
pubmed: 32376872
doi: 10.1038/s41386-020-0699-7
pii: 10.1038/s41386-020-0699-7
pmc: PMC7414102
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

1405

Commentaires et corrections

Type : ErratumFor

Auteurs

Cristan A Farmer (CA)

Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Jessica R Gilbert (JR)

Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Ruin Moaddel (R)

National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.

Jomy George (J)

Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health, Bethesda, MD, USA.

Lilian Adeojo (L)

Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health, Bethesda, MD, USA.

Jacqueline Lovett (J)

National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.

Allison C Nugent (AC)

Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Magnetoencephalography Core Facility, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Bashkim Kadriu (B)

Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Peixiong Yuan (P)

Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Todd D Gould (TD)

Departments of Psychiatry, Pharmacology, and Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD, USA.
Veterans Affairs Maryland Health Care System, Baltimore, MD, USA.

Lawrence T Park (LT)

Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
ORCID: 0000-0002-6570-686X

Carlos A Zarate (CA)

Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. zaratec@mail.nih.gov.

Classifications MeSH